Scholars Central

Review articlePublished 21 Jan 2015

From atherosclerosis to cabg

Authors: Mohammad Ali Sheikhi, Ahmad Ebadi, Asghar Ramezani, Behnam Gholizadeh

International Journal of Bioassays

Volume 4 · Issue 2 · Pages 3676–3681

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Ischemic heart disease (IHD) is diagnosed in approximately 30-34% patients who undergo surgery. In other words, 1 out of 3 patients scheduled for surgery is an IHD patient. Cardiovascular diseases are in fact the main health problem in Iran. From 44 million surgeries performed in the US in 2003, 6.8 million were related to the cardiovascular system, 467,000 were related to coronary artery bypass grafting (CABG), and 93,000 were valve-related. The annual cost of coronary artery diseases in the US is nearly $142 billion (2,3,4,9). Coronary artery bypass grafting (CABG) is a common treatment method for ischemic heart disease. This surgery is not only essential to survival, but also relieves the angina pains and helps increase the quality of life (5-9)

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in International Journal of Bioassays.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Bioassays
  • SubjectCardiology
  • BylineArticles whose byline prints “Mohammad Ali Sheikhi”
  • BylineArticles whose byline prints “Ahmad Ebadi”
  • BylineArticles whose byline prints “Asghar Ramezani”
  • BylineArticles whose byline prints “Behnam Gholizadeh”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels